“The verdict is a bit out” on whether use of an anti-malaria drugs is effective in treating COVID-19, Dr. Nahid Bhadelia says.
France Dernières Nouvelles, France Actualités
Similar News:Vous pouvez également lire des articles d'actualité similaires à celui-ci que nous avons collectés auprès d'autres sources d'information.
US FDA issues limited emergency use authorization for two drugs usually used to treat malariaThe novel coronavirus pandemic continues to impact countries worldwide, particularly in Europe and the US. Follow here for live updates.
Lire la suite »
Coronavirus live updates: FDA gives anti-malaria drugs emergency approval to treat COVID-19CORONAVIRUS LATEST: • FDA gives anti-malaria drugs emergency approval to treat COVID-19. • Pandemic of novel coronavirus has claimed the lives of more than 34,000 people across the globe. • There are now more than 723,000 diagnosed cases of COVID-19.
Lire la suite »
Coronavirus live updates: FDA gives anti-malaria drugs emergency approval to treat COVID-19A pandemic of the novel coronavirus has claimed the lives of more than 35,000 people across the globe. There are now more than 737,000 diagnosed cases of COVID-19, according to data compiled by the Center for Systems Science and Engineering at Johns Hopkins University. With more than 143,000 diagnosed
Lire la suite »
FDA approves new 15-minute coronavirus testThe test can deliver "results in as little as five minutes and negative results in 13 minutes," its developer, Abbott, said in a statement.
Lire la suite »
FDA issues emergency authorization of anti-malaria drug for coronavirus careThe Food and Drug Administration issued an emergency use authorization for decades-old malaria drugs championed by President Donald Trump for coronavirus treatment despite scant evidence
Lire la suite »
Abbott surges 11% after FDA approval of 5-minute coronavirus test (ABT) | Markets InsiderAbbott Laboratories announced Friday that the US Food and Drug Administration granted emergency use of its ID NOW COVID-19 test. Shares su...
Lire la suite »